Product Details for ANDA 080205
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
2MEQ/ML
Marketing Status: Prescription
1MEQ/ML
Marketing Status: Discontinued
2.4MEQ/ML
Marketing Status: Discontinued
3.2MEQ/ML
Marketing Status: Discontinued
2MEQ/ML
Marketing Status: Prescription
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2MEQ/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A080205
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2MEQ/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AP
Application Number: A080205
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Prescription
Patent and Exclusivity Information
1MEQ/ML
Marketing Status: Discontinued
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
2.4MEQ/ML
Marketing Status: Discontinued
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.4MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
POTASSIUM CHLORIDE (POTASSIUM CHLORIDE)
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 2.4MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
3.2MEQ/ML
Marketing Status: Discontinued
Active Ingredient: POTASSIUM CHLORIDE
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.2MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: POTASSIUM CHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 3.2MEQ/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A080205
Product Number: 005
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: HOSPIRA INC
Marketing Status: Discontinued
Patent and Exclusivity Information